Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NRC Group ASA - Acquisition of own shares

NRC Group ASA (the "Company"') has today acquired 21,000 shares in the Company through broker at an average price of NOK 31.86 per share. The Company's total holding of treasury shares after this transaction is 119,684 shares. For further information, please contact: CFO Dag Fladby, telephone: +47 90 89 19 35. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Össur hf: Approval notice from FTC received regarding acquisition of College Park Industries

7 April 2020  Approval notice from FTC received regarding acquisition of College Park Industries As announced on 19 July 2019, Össur had signed an agreement to acquire College Park Industries (CPI), a global provider of prosthetic devices and supporting services headquartered in Michigan, USA. Closing of the transaction was subject to certain closing conditions including regulatory review. Today, Össur received approval notice from the United States Federal Trade Commission (FTC) regarding the acquisition of CPI, conditioned on divestiture of CPI´s bionic elbow business, sold under

Photocure ASA: Market update #2

Oslo, Norway, 7 April 2020: The Board of Directors and Management of Photocure ASA (OSE:PHO) follow the COVID-19 situation closely and have implemented strict measures to ensure the safety of patients, customers, employees and business partners while maintaining an uninterrupted level of service and supply. The company today provides the second COVID-19 Oslo Stock Exchange notification to ensure updated and transparent stakeholder information.“The pandemic continues to bring tremendous hardship on those affected by the virus; families, communities and business. The Photocure team expresses

Celiac disease linked to increased mortality

People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease in recent years and better access to gluten-free food. This is according to a new study from Karolinska Institutet in Sweden and Columbia University in the U.S. published in the prestigious journal JAMA. Celiac disease was linked to increased risk of death from cardiovascular disease, cancer and respiratory disease.Previous studies have demonstrated a modest but persistent increased risk of premature death in patients with celiac disease. However, in recent years, more people with

Notice of Kesko’s Annual General Meeting

Kesko Corporation's shareholders are invited to the Annual General Meeting to be held at Kesko Corporation’s main office building K-Kampus at Työpajankatu 12, 00580 Helsinki, on 28 April 2020, starting at 10.30 am EET. Reception for those registered for the meeting will open and voting tickets will be provided starting at 9.30 am EET. There will be no refreshments served or gifts given at the meeting.Kesko takes the COVID-19 coronavirus epidemic very seriously. Kesko urges its shareholders to seriously consider not attending the Annual General Meeting in person, as the meeting can only be

#20-127 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-126 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

IRLAB publishes the annual report for 2019

IRLAB announced today that the company’s annual report for fiscal year 2019, in Swedish, is published and available on the company's website."We now have two drug candidates with new mechanisms of action that have delivered very positive results in Phase IIa studies for Parkinson’s; This confirms the power of innovation in our research platform ISP. We are now entering the “develop for launch” phase with mesdopetam and IRL752 and continues the development of our preclinical projects toward Phase I studies," says Nicholas Waters, CEO. IRLAB’s annual report for 2019, in Swedish, is

Bong postpones the Annual General Meeting 2020

Following the outbreak of Covid-19, Bong’s Board of Directors has decided to postpone the Annual General Meeting 2020 as a precautionary measure. The Annual General Meeting 2020 will be held no later than June 30, 2020 in accordance with current legislation. A new notice will be issued no later than four weeks before the AGM. Bong is one of the leading providers of envelope products in Europe that also offers solutions for distribution and packaging of information, advertising materials and lightweight goods. Important growth areas in the Group are packaging within retail and e-

Cantargia submits IND application for CAN04

Cantargia AB today announced that the application for a US IND regarding the antibody CAN04 has been submitted to the US FDA. CAN04, an antibody targeting interleukin 1 receptor accessory protein (IL1RAP), is currently being investigated for treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC) in phase IIa clinical development in Europe. The IND application concerns one new phase Ib clinical trial investigating CAN04 in combination with immunotherapy in selected cancer forms overexpressing IL1RAP.Cantargia develops antibody-based pharmaceuticals against the

Taking action to address the changed market sentiment

STOCKHOLM, Sweden - Nepa, a leading consumer research and analytics company, providing insight solutions to strengthen brands and drive sales by increased marketing effectiveness, is taking steps to address the increased uncertainty due to the corona virus. Nepa has decided to reduce the working hours for just over 120 employees in Sweden and Finland. Nepa will apply for government financial support to compensate for a significant part of the costs of retaining these employees. In Finland it means reduction of working time and salary. Furthermore, pay cuts of at least 20 per cent are

A sunny offering: Own the experience of natural light, not the system

This press release is based on the press release published in Swedish on April 7, 2020.Parans extends its offer of natural light. Parans goes from offering a system to offering a service. From spring 2020, it will be possible to lease sunlight via the Paransystem instead of buying it. Together with Parans' partner Siemens Financial Services, a complete service agreement is offered which includes all hardware and software. Parans, in collaboration with Siemens Financial Services, now has the opportunity to offer natural light to property owners, employers and everyone else who needs

Bambuser publishes prospectus supplement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. By reason of the press releases published by Bambuser AB (”Bambuser” or the ”Company”) on 2 April 2020 regarding a commercial agreement with Intersport, 6 April 2020 regarding the resignation by the chairman of the board, Fredrik Ramberg, 6

Episurf Medical announces outcome of preferential rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE UNITED KINGDOM, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFULThrough the rights issue, Episurf Medical AB (publ) (”Episurf Medical” or the ”Company”) will receive proceeds amounting to approximately SEK 51m before deduction of costs related to the rights issue. 13,884,906 shares, corresponding to approximately 40.7 per cent of the rights issue, were

Notification of major holdings in the Company

TORM plc has been notified of the following transaction in TORM plc securities: TR-1: Standard form for notification of major holdings. [][][][][][][]NOTIFICATION OF MAJOR HOLDINGS (tobe sent to the relevant issuer andto the FCA in Microsoft Word formatif possible)[i] 1a. Identity of the issuer or the TORM plcunderlying issuer of existing sharesto which voting rights areattached[ii]:1b. Please indicate if the issuer isa non-UK issuer (please mark with an“X” if appropriate)Non-UK issuer2. Reason for the notification(please mark the

Lehto Group Plc: Lehto withdraws its guidance on 2020 financial outlook

Lehto Group PlcInsider information7 April 2020 at 4.10 p.m. (EET)Corona virus pandemic has created uncertainty in Lehto’s business environment and the visibility has weakened. So far Lehto’s projects have progressed nearly without interruptions but starts of some new projects are delaying because of decisions made by the customers. The company sees risks related to sales, project execution and availability of materials, subcontracting resources and labour resources. Realization of the risks would have effects on Lehto’s year 2020 net sales, profitability and financial position. Due

PROVENTUS CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS II

Stockholm, 7 April 2020 Proventus Capital today announces that, at the close of business on 31 March 2020, the Net Asset Value of the Proventus Capital Partners II participation loan amounted to SEK 13,567 per debenture. SEK 354 per debenture will be distributed as Ordinary Income to our debenture holders on 16 April 2020. No partial repayment will be done for the quarter. Proventus Capital Partners II’s assets are composed of 100 per cent privately issued corporate loans. Proventus Capital is an active credit investor and loan provider to Northern and Western European companies

PROVENTUS CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS ALPHA

Stockholm, 7 April 2020 Proventus Capital today announces that, at the close of business on 31 March 2020, the Net Asset Value of Proventus Capital Partners Alpha participation loan amounted to SEK 872,458 per debenture. SEK 12,444 per debenture will be distributed as Ordinary Income to our debenture holders on 16 April 2020. No partial repayment will be done for the quarter. Proventus Capital Partners Alpha’s assets are composed of 100 per cent privately issued corporate loans. During the quarter no private loans were fully repaid. Proventus Capital is an active credit

PROVENTUS CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS III

Stockholm, 7 April 2020 Proventus Capital today announces that, at the close of business on 31 March 2020, the Net Asset Value per participation loan debentures of Proventus Capital Partners III, is SEK 444,278 for series A and SEK 11,111,506 for series B. SEK 12,418 per series A debenture and SEK 315,007 per series B debenture will be distributed as Ordinary Income to our debenture holders on 16 April 2020. SEK 19,000 per series A debenture and SEK 475,000 per series B debenture will be distributed as partial repayment of the debenture loan on 30 April 2020. Proventus Capital

Vestas Wind Systems A/S' Articles of Association

Vestas Wind Systems A/S, Aarhus, 7 April 2020  Vestas Wind Systems A/S' Articles of Association Articles of Association for Vestas Wind Systems A/S have been updated as adopted by the Annual General Meeting on 7 April 2020 and are hereby attached. The share capital reduction, ref. item 7.3 on the agenda for the Annual General Meeting 2020, will not take effect before expiry of the creditors’ notification period, at which point the Articles of Association will be updated again to reflect this.

Vestas Wind Systems A/S’ Annual General Meeting on 7 April 2020

Vestas Wind Systems A/S, Aarhus, 7 April 2020Company announcement No. 11/2020  Vestas Wind Systems A/S’ Annual General Meeting on 7 April 2020 The Annual General Meeting of Vestas Wind Systems A/S was held today. Agenda and resolutions 1. The Board of Directors’ report on the company’s activities during the past year The report is not subject for voting. The Annual General Meeting took note of the report.    2. Presentation and adoption of the annual report The annual report 2019 was adopted. 3. Resolution for the allocation of the result of the year according to

Raisio plc: Managers´ transactions

Raisio plc    Managers´ transactions 7 April 2020 MANAGERS’ TRANSACTIONS Person subject to the notification requirementName: Kuusniemi, PekkaPosition: Chief Executive OfficerIssuer: Raisio OyjLEI: 74370083282NHIP4QD02 Notification type: INITIAL NOTIFICATIONReference number: 74370083282NHIP4QD02_20200407125213_2____________________________________________ Transaction date: 2020-04-07Venue not applicableInstrument type: SHAREISIN: FI0009002943Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION Transaction details(1): Volume: 29,

Bulletin from the Annual Shareholders’ Meeting of Dometic Group AB (publ)

The annual shareholders’ meeting of Dometic Group AB (publ) was held on Tuesday, April 7, 2020 in Stockholm. Income Statement and Balance Sheet and Discharge of Liability The annual shareholders’ meeting adopted the income statement and balance sheet and the consolidated income statement and balance sheet for the financial year 2019 as presented. The members of the board of directors and the company’s CEO were discharged from liability in respect of their management of the company’s business during the period covered by the annual report. Dividend In accordance with the proposal

There are no items matching the current filter
There are no more items matching the current filter
Back to top